Colorectal cancer (CRC), also known as bowel cancer and colon cancer, is the development of cancer from the colon or rectum. Globally, colorectal cancer is the third most common type of cancer in both men and women making up about 10% of all cases. Currently, there is a significant focus on development of drugs for […]

Read More →

Gastro-Intestinal (GI) drugs market is a potentially huge market with many different indications, drug types and treatment regimens. Transparency Market Research and PRNewswire reports predict the global GI drugs market to grow with a CAGR between 4.5 % and 5.0 % from 2017 to 2023. While, it was worth USD 46.5 Billion in 2016, it […]

Read More →

Alopecia is a condition in which hairs are lost from some or all areas of the body. In fact, alopecia areata is also known as spot baldness for this reason. Most commonly, patients have bald spots on their scalps about the size of a coin. There are three (3) well-known types of Alopecia Alopecia areata […]

Read More →

Identification and selection of clinical trial sites and clinical investigators remain one of the first and most crucial decisions that clinical trial managers take. This also happens to be the one that may define the success (or, failure) of the project. We had been seeing the impact of site/investigator identification on clinical trial successes time […]

Read More →

With the clinical research industry taking more globalized form than local, and development has a global impact. So, when four major organizations of an Industry goes through transformations, the dynamics of the industry changes. This is what is happening currently with the Clinical Research Industry as well. Geographically, the market is focused primarily in North […]

Read More →

From that first randomized clinical trial on board HMS Salisbury in 1747, we’ve come a long way! Still, there is more to be done. More horizons are to be explored, more medicines to be developed, and more patients to be cured. Let’s celebrate May 20, 2017 as a new beginning to even better, even faster […]

Read More →

The clinical research industry has grown to be an integral part of the bigger pharmaceutical industry today. It helps pharma companies conduct research faster and in much more productive ways. In today’s drug development cost of 2.6 billion per new molecule, clinical trials hold about 70% share, which means that any changes in this industry […]

Read More →

Taiwan is emerging as a big player in the Asian clinical trial market. There are many advantages of conducting clinical trials in Taiwan, which have been discussed in Part 1 of this blog. In this part, let’s talk a bit about the clinical trial regulatory scenario in Taiwan, including the approvals required and how to be prepared […]

Read More →

Taiwan has one of the most progressive healthcare systems in the world and is a major hub for clinical research in the Asia-Pacific region. Currently, it is well-positioned to meet the growing demands of the global clinical trial market. Top 5 reasons to choose Taiwan for your clinical trials? There are many good reasons to go to […]

Read More →

Investigators, from Brazil who were specialized in Allergy and Immunology segment, were invited to participate in feasibility of a new phase II clinical trial.   What’s was the trial about? It’s a phase II – dose selection and confirmatory – clinical trial planned to be conducted in Brazil. What kind of patients were required for this clinical […]

Read More →